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Abstract 1 
Background: Robotic rollators enhance the basic functions of established devices by technically 2 
advanced physical, cognitive, or sensory support to increase autonomy in persons with severe 3 
impairment. In the evaluation of such Ambient Assisted Living solutions, both the technical and user 4 
perspectives are important to prove usability, effectiveness, and safety, and to ensure adequate device 5 
application. 6 
Objective: The aim of this systematic review is to summarize the methodology of studies evaluating 7 
robotic rollators with focus on the user perspective and to give recommendations for future evaluation 8 
studies. 9 
Methods: A systematic literature search up to December 31, 2014 was conducted based on the 10 
Cochrane Review methodology using the electronic databases PubMed and IEEE Xplore. Articles 11 
were selected according to the following inclusion criteria: Evaluation studies of robotic rollators 12 
documenting human-robot interaction, no case reports, published in English language. 13 
Results: Twenty-eight studies were identified that met the predefined inclusion criteria. Large 14 
heterogeneity in the definitions of the target user group, study populations, study designs, and 15 
assessment methods was found across the included studies. No generic methodology to evaluate 16 
robotic rollators could be identified. We found major methodological shortcomings related to 17 
insufficient sample descriptions and sample sizes, and lack of appropriate, standardized and validated 18 
assessment methods. Long-term use in habitual environment was also not evaluated. 19 
Conclusions: Apart from the heterogeneity, methodological deficits in most of the identified studies 20 
became apparent. Recommendations for future evaluation studies include: clear definition of target 21 
user group, adequate selection of subjects, inclusion of other assistive mobility devices for 22 
comparison, evaluation of the habitual use of advanced prototypes, adequate assessment strategy with 23 
established, standardized and validated methods, and statistical analysis of study results. Assessment 24 
strategies may additionally focus on specific functionalities of the robotic rollators allowing an 25 
individually tailored assessment of innovative features to document their added value. 26 
 27 
Key words  28 
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Introduction 31 
In older persons, the ability to move independently represents a hallmark of autonomous living [1] 32 
and quality of life [2], while being physically active is associated with numerous positive health 33 
outcomes [3, 4]. However, sensory, motor or cognitive impairments restrict mobility in frail, older 34 
persons [5]. Motor key functions such as standing, walking, or transfers are substantial challenges for 35 
their daily activities leading to high risk exposure of falls as documented in residents of senior homes 36 
[6]. Effects of motor impairment are augmented by sensory deficits such as visual impairment, leading 37 
to restricted functional independence [7], or by cognitive impairment, leading to spatio-temporal 38 
disorientation or executive dysfunction [8]. To overcome or compensate for such impairments and to 39 
improve the quality of life of affected persons, assistive devices as in walking aids (e.g. canes, 40 
walkers, rollators) have been developed with an early focus on mobility support. They provide support 41 
of postural stability and mobility [9], reduce risk of falling [10], and improve activity and participation 42 
[11]. However, such conventional mobility devices may not cover the needs of persons suffering from 43 
major functional or cognitive impairments.  44 
In the context of Ambient Assisted Living (AAL), robotically augmented rollators with various 45 
high-tech functionalities have been developed to provide physical, sensory and cognitive assistance, 46 
and/or health monitoring for further support [12]. The development and evaluation of such a robotic 47 
rollator (RR) is still a new, emerging research field mainly driven by technical engineering goals. 48 
However, as technical functionalities translate into assistive devices for use of the target population, 49 
for which these have been developed, the human-robot interaction and user perspective shifts in the 50 
development focus. Apart from the sheer technical evaluation of concepts and functionalities, needs, 51 
requirements, and preferences of potential users will have to guide the development and evaluation of 52 
assistive technology devices [13, 14]. In addition to technical testing, which verifies the functional 53 
capability of devices, an evaluation with focus on user performance, physical demands, and subjective 54 
experiences of the RR is essential to prove the usability, ensure safety, and demonstrate the added 55 
value for the intended user group. The change from technical to user perspective may, however, lead 56 
to specific methodological challenges including the study design and assessment strategy. To our 57 
knowledge, no systematic review on the evaluation of RRs with focus on the user perspective has been 58 
published. Therefore, the aim of this systematic review was to summarize the methodology of studies 59 
evaluating the human-robot interaction from a user perspective and to give recommendations for 60 
future evaluation studies. 61 
 62 
Methods 63 
Initial search terms were compiled and iteratively refined by team members with expertise in the 64 
clinical and in the technical research field. The literature search was conducted using the electronic 65 
databases PubMed and IEEE Xplore. Search terms included both controlled vocabulary (i.e. MeSH 66 
Terms, IEEE Terms) and keywords of relevance identified during searches. The detailed search 67 
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strategy used in PubMed, which was modified for IEEE Xplore, is presented in the online 68 
supplementary table 1.  69 
Manual searches were performed to identify additional studies by scanning reference lists of 70 
relevant articles and by reviewing key authors’ own databases. Studies were searched with focus on 71 
the evaluation of a RR (or robotic wheeled walker) by experiments, trials, or interventions in human 72 
beings independent of the type of outcome measurement. No restrictions regarding age or health status 73 
of the subjects were made. Single case reports were excluded. For the purpose of this review the term 74 
‘robotic’ includes the normal function of a rollator enhanced by additional physical, sensory, or 75 
cognitive robotic support while walking, also including sit-to-stand transfers. Studies evaluating solely 76 
monitoring functionalities without taking into account any user supporting functionalities or the 77 
subjective user experience were excluded. The search was limited to articles in the English language 78 
published up to December 31, 2014.  79 
The selection process was conducted following the methodology as described in the method 80 
guidelines of the Cochrane Collaboration [15]. Titles and abstracts were identified by the standardized 81 
search strategy. For abstracts which met the inclusion criteria or for those with unclear status, full-text 82 
articles were analyzed for inclusion. Each step of study selection, based on predefined eligibility 83 
criteria, was performed independently by two reviewers (PU, CW). Any disagreements were resolved 84 
by consensus or third-party adjudication (KH). After inclusion, data on the user group, sample 85 
characteristics, and the methodological approach were extracted by one researcher (CW) and 86 
confirmed by two other researchers (PU, DS). If an article described more than one study, the results 87 
for each study were extracted separately.  88 
 89 
Results 90 
A total of 8989 articles were identified through database searching, and another 79 were added 91 
through manual searches. After removing duplicates, the initial search resulted in 8876 articles. Of 92 
these, 235 were found to be related to the search topic based on title and abstract. After reviewing full 93 
texts, 148 articles were excluded as they did not meet the predefined inclusion criteria (Fig. 1). 94 
Another 63 were discarded, as these articles described either identical experiments with the same RR, 95 
or various stages of development of a certain RR. In both cases, the article providing the most 96 
comprehensive information with focus on the user perspective was included. If different articles 97 
contained similar information, the one with the most recent development stage was included. Twenty-98 
four articles published between 2001 and 2015 were identified for inclusion in the review. As two 99 
articles reported on two [16, 17] and one article on three independent studies [18], the final data 100 
extraction was based on 28 studies
†
. The detailed review results extracted for each study are presented 101 
                                                     
† When necessary, the individual studies of these articles are distinguished with numeric coding (i.e. [161,2], [171,2], [181,2,3]) 
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in the online supplementary table 2, containing information on the names of devices, the definition of 102 
user groups, study sample, study object, study design, and selected assessment methods. 103 
 104 
(Please insert figure 1 about here) 105 
Fig. 1: Flow chart of the study selection process and extraction methodology 106 
 107 
User Group Definitions 108 
Apart from two articles [19, 20], all mentioned a target user group for the RR; however, their 109 
definition differed substantially in accuracy and explicitness. Five articles provided a generic 110 
description in broad terms such as ‘elderly (disabled) people’‘ [21-25], two defined users by setting-111 
specific characteristics such as ‘persons in nursing and assisted living homes’, partly amended by 112 
disease-related criteria (e.g. Alzheimer’s disease, stroke) [26, 27], and ten provided brief information 113 
on users’ motor-functional (e.g. ‘with mobility problems’), cognitive (e.g. ‘with cognitive 114 
impairment’) and/or visual status (e.g. ‘visually impaired’) [17, 18, 28-35], but without staging 115 
impairment levels based on any screening or assessment instrument. Three articles described users by 116 
disease categories (e.g. Parkinson’s disease, hemiplegia) [16, 36, 37] without detailed information on 117 
the patients’ functional impairment level. Specific impairment-related definitions based on established, 118 
validated assessment methods (i.e. Walking Index for Spinal Cord Injury [WISCI II], Functional 119 
Ambulation Classification) were documented in only two articles [12, 38]. 120 
 121 
Study Samples 122 
The mean sample size of studies was 7.2 (standard deviation [SD]  4.3). The exact number of 123 
subjects was not reported in five studies [18
1,2,3
, 35, 37]. No study presented a sample size calculation.  124 
Samples differed considerably regarding age, impairments, or diseases. The age of subjects ranged 125 







, 20, 23, 25, 27-29, 35, 37]. 127 





, 26, 27, 30-32, 34, 36, 38], whereas a convenient (e.g. ‘ordinary adult 129 
males’) [19, 20, 23, 24, 33], mixed (e.g. ‘healthy subjects and subjects with motor and cognitive 130 
impairment’) [181,2,3, 21, 22, 29, 35, 37] or setting-specific sample (e.g. ‘residents of retirement 131 
facility’) [28] was used in 14 studies. In studies including impaired subjects, definitions and staging of 132 




, 22, 26, 29-32, 34, 35, 37, 133 
38]. In only six studies, motor-functional or cognitive impairment levels were defined by established 134 
and validated screening or assessment instruments (e.g. Timed up and Go [TUG], Mini-Mental State 135 
Examination) [12, 16
1,2
, 21, 27, 36].  136 
In ten studies, subjects did not match with the predefined user group [18
1,2,3
, 22-24, 27, 28, 33, 37]. 137 
However, due to the unspecific and wide-ranging user group definitions given in a number of articles, 138 
most studies (15 of 28) were carried out with subjects who were covered by these broad definitions 139 
 





, 21, 26, 29-32, 34-36, 38]. In three studies, a user group definition and/or a description 140 
of the study sample was completely missing [19, 20, 25]. 141 
 142 
Design of Studies 143 
Depending on study objectives, three different types of studies were performed: (1) observational 144 
studies; (2) comparative studies, or (3) interventional studies. 145 
 146 
Observational Studies 147 
Fourteen articles reported on observational studies [12, 18, 20, 22, 24, 29, 35, 37] or single 148 
observational experiments as part of their studies [16, 17, 23, 26, 28, 33], focusing predominantly on 149 
the verification of technical capability and/or the subjective user evaluation of RR. User performance 150 
was used as the study object in only one of these studies [26]. In observational studies/experiments, 151 
outcomes were only descriptively presented, without providing any reference values. 152 
 153 
Comparative Studies 154 
Fourteen articles included comparative studies [19, 21, 25, 27, 28, 30-32, 34, 38] or single 155 
comparative experiments in addition to observations [16, 17, 26, 33]. Comparisons were further 156 
distinguished into four categories: (1) ‘inter-device comparisons’ in which RR and conventional 157 
devices (e.g. cane, folding/wheeled walker) or fully unassisted walking/sit-to-stand transfers were 158 
compared [19, 21, 26, 27, 30, 32, 34, 38]; (2) ‘intra-device comparisons’ in which different assistance 159 
levels (e.g. activated vs. non-activated obstacle avoidance), interface designs, or development stages of 160 
the same RR were compared [17
2
, 19, 25-28, 30, 31, 33, 34]; (3) comparisons in a pre/post-test study 161 
design with focus on the user experience [34] or the technical functionality [23], assessed before and 162 
after/over a series of trials; and (4) comparisons between outcomes of a newly developed robotic 163 




Interventional Studies 166 
Two articles described studies that used an interventional approach, providing training 167 
opportunities with the RR [16, 36]. In one study, the subjects’ gait performance with the robotic gait 168 
assistance system was assessed on six consecutive days [16
1
]. However, subjects seemed to use the RR 169 
only during test procedures and not in their daily routine. Although the ultimate research hypothesis 170 
for this ‘interventional’ approach was lacking, we assumed that the repeated use represented a type of 171 
training intervention in order for the subjects to get used to using the RR. In the other study, a four-172 
week randomized controlled trial was conducted to evaluate the effects of ambulation training with a 173 
RR compared to a traditional rehabilitation therapy method using parallel bars [36]. In this study, 174 
assessment methods were used to evaluate the subjects’ motor-functional performance after the robot-175 
assisted training intervention. 176 
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 177 
Statistical Analysis 178 
An inferential statistical analysis of outcomes was included in only three studies [19, 34, 36]. In 25 179 
studies, outcomes were presented using solely descriptive or qualitative data (e.g. frequencies, means, 180 






, 20-33, 35, 37, 38].  181 
 182 
Assessment Methods 183 
Assessment measures used in identified studies can be classified into five categories:  184 
(1) established clinical performance-based measures assessing  subjects’ functional ability to 185 
perform a requested task by simple quantitative time-, range-, or rating-based outcomes (e.g. gait 186 
speed, walking distance, rating score) or by more detailed, qualitative outcomes captured by external 187 
technical measures (e.g. step time, double support time); (2) tailored assessment methods in terms of 188 
self-designed performance-based measures specifically tailored to specific functionalities of the RR 189 
(e.g. guidance system, obstacle avoidance). In addition to simple quantifiable time- or count-based 190 
outcomes (e.g. walking time, number of collisions), these assessment methods predominantly used 191 
more technique-based and qualitative outcomes (e.g. path deviation, distance to obstacle); (3) 192 
assessment methods used to evaluate the subject’s physical and physiological demands during the use 193 
of the RR; (4) subjective evaluation measures to assess a user’s experience with the RR; and (5) 194 
technical evaluation measures to assess the technical capability of the RR. 195 




, 20, 22-24, 33], exclusively 196 
focused on the technical verification of the RR with limited relevance for the user perspective, we do 197 
not further address and discuss these measures in this review.  198 
 199 
Clinical Performance-Based Measures  200 
Established clinical performance-based measures were used in three studies [21, 32, 36]. In one of 201 
these, the subjects’ gait and functional performance with the RR were assessed by the 4-meter walk 202 
test (4MWT), a modified version of the TUG, and spatio-temporal gait parameters (i.e. step time, 203 
double support time) captured by video camera during both tests [21]. Other studies documented the 204 
subjects’ motor performance by the 6-minute walk test (6mWT), 10-meter walk test (10MWT), and 205 
Performance Oriented Mobility Assessment (POMA) [36] or only by the 10MWT [32]. The most 206 
frequently used outcomes were gait speed [21, 32, 36], completion time [21], or walking distance and 207 
rating scores for functional performance (POMA) [36]. 208 
In one study, an established screening test for assessing the functional ability of subjects to perform 209 
activities of daily living (ADL) was used (Barthel ADL Index) [36]. 210 
 211 
Tailored Assessment Measures 212 
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In ten studies, assessment strategies included self-designed performance-based measures 213 




, 19, 25-28, 31, 34]. Obstacle 214 
avoidance and guidance systems were evaluated while subjects completed walking paths  [25, 28] or 215 
obstacle courses [17
2
, 31, 34], navigation and localization systems while performing navigational tasks 216 
[26, 27], and gait assistance systems by analyzing the subject’s gait during robot-assisted walking 217 
[16
1,2
, 19]. Simple quantifiable outcomes of these tests included number of collisions [26, 31, 34], 218 
reorientations [34], navigational mistakes [27] or abnormal gait patterns [16
1,2
], walking time [34], or 219 
achievement of task [26]. More specifically tailored, technique-based outcomes, as used in eight 220 
studies, comprised of deviations from an optimal path [17
2
, 25, 28, 31], distance to obstacles [17, 26], 221 
maximum speed and walking distance [26], mean and SD of robot’s velocity [19], and gait variability 222 
(i.e. SD of gait speed/step length) [16
1,2
]. To obtain such technically advanced outcomes, five studies 223 
used the data flow created by the technical systems installed on the RR, including laser rangefinders 224 
(LRF) [16
1,2
, 28], a video camera and sonar sensors [17
2
], or a web camera [31]. In the other three 225 
studies, information on the technical measure to capture these outcomes was nonexistent [19, 25, 26]. 226 
Out of the studies that determined outcomes with the robot-integrated technical systems, only one 227 
seemed to process raw data (LRF data) into outcome variables (i.e. path deviation) by using an already 228 
established method for robust position estimation of mobile robots in indoor environments (‘Monte 229 
Carlo localization’) [28]. In the other four studies, it remained unclear whether raw data was analyzed 230 




, 31].  231 
In two inter-device comparative studies, a bicycle speedometer attached to the conventional device 232 
[16] or a LRF placed in the test environment [26] was used to assess technically advanced outcomes 233 
such as walking distance or gait variability also when not using the RR. However, a reference, or any 234 
information on the psychometric quality of these methods, was missing in both studies.  235 
In four studies including tailored assessment measures, test procedures appear to be non-236 
standardized [16
2
, 26, 34] or have been insufficiently described [28].  237 
 238 
Evaluation of Physical and Physiological Demands 239 
Four studies assessed subjects’ physical and physiological demands with motorized RR during 240 
time-based performance-based measures (i.e. navigational trail, 10MWT) [26, 32] or during walking 241 
with standardized gait speed [19, 33]. In two studies, the exertion of force applied to steer the RR was 242 
measured using the force/torque sensors integrated on the robot’s handles [19, 26]. One also reported 243 
on forces required to operate a conventional walker, but did not mention the method to capture these 244 
forces [26]. The other study additionally evaluated the oxygen consumption (VO2) and metabolic cost 245 
of transport (metabolic cost per unit of mass and distance travelled) during robot-assisted gait using 246 
open-circuit respirometry [19]. In the remaining two studies, the muscle activity in the lower 247 
extremities was recorded by electromyography (EMG) [32, 33], and one also measured torso 248 
kinematics by a tri-axial accelerometer attached to the subject’s back [32].  249 
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 250 
Subjective Evaluation Measures  251 







,19, 22-24, 26-30, 34, 35, 37, 38]. However, assessment instruments to perform such 253 
subjective evaluations varied widely in methodological quality. Nine studies documented solely non-254 






, 22, 24, 28, 29, 35, 37], three used 255 
standardized (dichotomous) questions [27, 30, 38], four used self-designed structured questionnaires, 256 
each with different multi-stage rating scales (e.g. 1 to 5, 0 to 100) [12, 17
1
, 19, 34], two mentioned the 257 
use of questionnaires but did not provide detailed information on contents or a reference [18
3
, 26], and 258 
one presented results of the subjective evaluation by response categories referring to different items 259 
but without mentioning the assessment instrument used for this purpose [23]. Most frequently used 260 
outcomes of standardized surveys included maneuverability [12, 17
1
, 38], safety [12, 30, 38], and 261 
comfort [12, 19, 34]. 262 
 263 
Discussion 264 
The aim of this systematic review was to summarize the methodology of evaluation studies of RRs 265 
with focus on the user perspective. Identified studies showed large heterogeneity in definitions of 266 
potential users, study population, study design, and assessment methods. We found major 267 
methodological shortcomings related to insufficient sample descriptions and sample sizes, lack of 268 
appropriate, standardized and validated assessment instruments, and lack of statistical analysis of 269 
study results. No generic methodology to evaluate RRs could be identified.  270 
 271 
User Group Definitions 272 
The majority of user group definitions seemed inadequate to guide a technical development of an 273 
AAL system. Generic, setting-specific, non-specific impairment-based or disease-oriented definitions 274 
do not relate to specific functional impairments of potential users, but cover users with a wide range of 275 
different functional abilities and requirements. The effective design of AAL systems in such 276 
heterogeneous user groups may be not feasible. The main goal of an AAL system should rather be to 277 
overcome or compensate for specific impaired functions. Clear impairment-related definitions are 278 
therefore mandatory to specifically tailor AAL developments for specific impairments of users and to 279 
ensure that innovative functionalities effectively address a user’s needs. When such specific 280 
impairment-related definitions are additionally based on standardized and validated assessment 281 
methods with established cut-off values, a general comparability of developments and evaluations will 282 
be feasible. 283 
Definitions according to impairment levels will in turn allow specifications such as risk 284 
stratification of potential users. With this, the user group will be further classified opening up the 285 
option to exclude persons with no or minor impairment, with no need for assistive devices, or with 286 
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advanced impairment or unacceptable risk exposure when using the device (triage). Another 287 
specification may focus on the main function of the specific device. For example, when an AAL 288 
system such as a RR basically supports gait performance, a specific definition based on standardized 289 
and validated gait assessment (e.g. 10MWT) will be superior compared to less specific definitions 290 
such as general functional scores (e.g. Barthel ADL Index).  291 
As the user group of RRs may be old and multi-morbid persons, also highly prevalent age-292 
associated impairments might be included in the definitions, depending on the specific functionalities 293 
or complexity of devices (e.g. inclusion of cognitive impairment with respect to navigation functions 294 
in disoriented persons). 295 
 296 
Study Samples 297 
Overall, sample sizes seemed rather limited to give a consistent picture of the user perspective. 298 
Surprisingly, the statistical analysis of documented data was not in the focus of studies as only a very 299 
limited number included such analyses (3 of 28) and none of these presented a sample size calculation 300 
as a prerequisite of statistical analysis.  301 
A remarkable number of studies (10 of 28) evaluated RRs in persons who were not covered by the 302 
predefined user group, considerably limiting the user perspective of these studies. Study results with 303 
inadequate, convenient, or insufficiently described samples may not suffice to allow conclusions for 304 
persons with specific impairments which may represent the potential users of the RR. To ensure that 305 
RRs meet a user’s needs and requirements and become successful in the market, it seems mandatory to 306 
involve the intended users at all stages of the design and evaluation process of such assistive robotic 307 
technologies [39-41].  308 
 309 
Design of Studies 310 
Observational Studies 311 
The most heterogeneous group of studies covered observational studies that used solely descriptive 312 
data presentations without providing any reference or comparative values. Findings and conclusions of 313 
these studies were thus mainly based on the authors’ subjective perception and appraisal. However, 314 
when using standardized and validated outcome measures with well-established cut-off values or other 315 
assistive mobility devices for comparison, such observations lose their merely subjective and study-316 
specific nature and enable the objective appraisal of outcomes related to other studies or the 317 
documentation of an added value of the RR compared to other devices. From a user as well as a 318 
technical perspective, observational studies that descriptively presented non-classifiable or non-319 
comparable outcomes therefore seem to have  limited value. 320 
 321 
Comparative Studies 322 
 
- 11 - 
The documentation and perception of an added value of the RR is of utmost importance for 323 
potential users. Innovative high-tech developments may be fascinating and mandatory for engineering 324 
research; however, they may also lead to rather complicated devices for everyday use, not easy to 325 
maneuver, too complex to operate, or too expensive to afford. A comparison of RRs with established, 326 
low-tech devices (‘inter-device comparative study design’) may therefore be useful to demonstrate to 327 
users the benefit of RR usage. 328 
Comparisons may also be used for the evaluation of single functionalities to document the effect of 329 
a specified functionality (e.g. activated guidance system) or the progress of a new development stage. 330 
Such an ‘intra-device comparative’ study design allows a tailored assessment of the subjects’ 331 
functional performances, physical and physiological demands, and user experience in specific 332 
assistance levels or development stages of the RR. 333 
Frail, older persons may initially be intimidated by the robot’s appearance in early stages of 334 
development (e.g. without casing, exposed hardware) which may in turn result in a more negative user 335 
perception before actually having used the RR. Subjective user evaluations, in a pre/ post-test study 336 
design, provide the opportunity to assess the subjects’ initial impressions of the RR and whether there 337 
are potentially negative prejudices, which may, however, be overcome after actual use of the RR. 338 
Independent of different types of comparative studies, such a study design should definitely include 339 
a statistical analysis to compare results which was however seldom used in the identified studies.  340 
 341 
Interventional Studies 342 
An interventional study design represents a new aspect in evaluation studies with strong focus on 343 
the user perspective. Newly developed RRs may not necessarily meet a user’s acceptance or provide 344 
usability and efficiency when using them for the first time. Insufficient training opportunities or 345 
instruction prior to assessment measures may jeopardize study outcomes [42]. An adequate practice 346 
time therefore seems mandatory to prevent initial problems in operating the RR, and may further 347 
increase the impact on outcomes. Particularly when comparing RRs with a subject’s own conventional 348 
assistive devices, brief instructions may not be sufficient, as subjects are already much more familiar 349 
and better trained with their own devices. 350 
Overall, we identified a lack of studies investigating usability of RRs in natural environments with 351 
adequate long-term evaluation of habitual use. The development and evaluation of RRs seemed to 352 
occur rather in engineering laboratories than in clinical settings, as already reported for other robotic 353 
assistance systems (e.g. service robots, robotic exoskeleton) [43]. This may be explained by the fact 354 
that most of the identified studies evaluated research prototypes in rather early development stages, 355 
not yet ready for market launch. In such stages, it is important to manipulate specific variables of a 356 
prototype in order to investigate their effects precisely and to optimize technical functionalities 357 
accordingly [41]. Since laboratory evaluations also require less time and provide highly standardized 358 
conditions, a restricted experimental study design may have been favored. However, for the ultimate 359 
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goal of RRs to assist mobility of impaired persons in daily life, tests for habitual use seem to be 360 
mandatory documenting risk, experience-based perception of use, and quality of life with high 361 
relevance for users as well as caregivers. 362 
 363 
Assessment Methods 364 
Clinical Performance-Based Measures 365 
Internationally well-established, clinical performance-based measures allow a worldwide 366 
comparability of results, but may be insufficient to cover the particular added value of specific robotic 367 
functionalities (e.g. obstacle avoidance, navigation assistance) as the outcome variables do not 368 
necessarily refer to the subjects’ abilities potentially affected by the RR [42]. In addition, clinical 369 
assessment methods may be limited by subjective rating (POMA) or limited with respect to less 370 
detailed, unidimensional outcomes such as gait speed (4MWT, 10MWT) or task completion time 371 
(TUG). Augmenting such measures with technical assessment systems (e.g. video analysis system) 372 
allows a multidimensional analysis of the subjects’ gait, including outcomes related to insecure gait or 373 
postural (in-)stability (e.g. width of base of support, double vs. single limb support) and reduction of 374 
falling risk as a main target of RRs.  375 
Even established and validated assessment methods may have their limitations when inadequately 376 
used. Outcomes such as gait speed (4MWT) and task completion time (TUG) may be inappropriate 377 
when comparing a non-motorized, conventional device with a motorized RR with limited maximum 378 
speed. In such comparisons, a superior outcome for the low-tech device seems almost mandatory and 379 
may indicate an insufficient selection of a study outcome. The use of ADL scales (e.g. Barthel ADL 380 
Index) to evaluate effects of a robot-assisted ambulation training appears also inappropriate, since they 381 
include, if any, only very few sub-items targeting the subject’s walking ability. 382 
Another potential methodological pitfall may be related to performance-based outcome variables 383 
with ambiguous consequences: a motorized RR will improve gait speed in less impaired persons 384 
without substantial risk. However, improved performance may be traded off by a substantially higher 385 
risk of falling in more impaired persons.  386 
 387 
Tailored Assessment Methods 388 
The quality of an assessment strategy substantially depends on the appropriateness of methods with 389 
focus on the newly developed functionalities to document the added value of RRs. Clinical 390 
performance-based measures may be attractive because of their well-established psychometric 391 
properties; however, they have been developed for clinical purpose and may not cover new 392 
functionalities in innovative assistive technologies [42]. An assessment strategy specifically tailored to 393 
the specific functionality to be evaluated may help to achieve this goal. In RR, depending on the 394 
functionalities installed, a huge data flow created by the robot-integrated sensing technique already 395 
exists to control motoror cognitive assistance systems. Using this data flow for assessment purposes 396 
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may allow highly qualitative and quantitative tailored assessments exactly tuned to the newly 397 
developed functionality in order to document the added value of the RR. For example, when focusing 398 
on functionalities providing navigational assistance, the data flow from laser sensors, which is used to 399 
feed back the position of the RR, could be processed into a superior assessment of walking trajectories 400 
during a navigational task. When using such data for assessment purpose, it seems mandatory to 401 
examine or to provide sufficient information on the psychometric qualities of the robot-integrated 402 
sensor technique and the analysis method used to process raw data into the outcome variables. 403 
However, it appeared that only one study used an already established method for this approach [28]. 404 
Furthermore, to ensure reliable, reproducible, and comparable outcomes, the test procedure of tailored 405 
assessment measures has to be also clearly standardized.  406 
 407 
Evaluation of Physical and Physiological Demands 408 
Measures such as EMG, respirometry, accelerometry, or measurements of applied steering forces 409 
to the RR allow a detailed insight into relevant physical and physiological effects on objective 410 
parameters, which may be indicators for the subject’s individual physical exertion (e.g. VO2, muscle 411 
activity). However, some of these rather laborious measures (e.g. EMG, respirometry) seem less 412 
amenable for old and multi-morbid persons and may have therefore been used predominantly in 413 
studies including only young, healthy adults [19, 33]. To prevent overtaxing by test conditions, 414 
alternative methods to evaluate physical exertion are available which may increase amenability by 415 
standardized and validated subjective rating (e.g. [44]). 416 
 417 
Subjective Evaluation Measures 418 
In studies including subjective evaluation measures, a wide range of methods (e.g. non-specific 419 
comments, self-designed questionnaires) related to a variety of different aspects of the subject’s 420 
experience with the RR was used which may considerably limit the comparability of outcomes. The 421 
overall lack of already established, validated questionnaires for the subjective evaluation of assistive 422 
technology (e.g. [45-47]) might be due to two reasons: (1) established questionnaires have been 423 
developed for a generic evaluation of a wide range of assistive technology devices but may be limited 424 
for evaluating specific functionalities of individual devices [45]; (2) some questionnaire items may 425 
also be inappropriate to evaluate prototypes after a short-term experiment in a restricted test scenario, 426 
covering aspects such as quality of life, usability in daily routine, durability, or services [45-47] whose 427 
assessment may only be feasible after habitual use of the devices over an extended period of time. 428 
However, the subjective evaluation measures used in the identified studies rather targeted the subject’s 429 
actual experience directly after using the RR. This may explain the use of self-developed 430 
questionnaires including items already assessable after short-term use in an artificial setting (e.g. 431 
maneuverability, safety, ease of use). However, only when these questionnaires have been validated 432 
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before application and internationally established cut-off values are available, such assessment 433 
instruments guarantee high psychometric quality and allow comparability of study results [48]. 434 
 435 
Limitations  436 
Only information available in the articles was evaluated in this review, although the authors may 437 
have used additional or more detailed methodology, not stated in articles. The fact that the evaluation 438 
of AAL prototypes may require elaborate and costly ethical application and study procedures 439 
(‘Medical Product Act’) may have prevented RRs to be tested in comprehensive studies with adequate 440 
sample sizes and the target user group as well as in natural environments with adequate long-term 441 
evaluation of habitual use. The role of clinical partners in AAL research projects may offer 442 
opportunities to solve such problems. Clinical partners may be able to provide specific impairment-443 
based user group definitions, to recruit a satisfactory number of potentially adequate subjects, and to 444 
investigate the habitual use of AAL systems in natural environments. 445 
 446 
Conclusions  447 
Apart from the heterogeneity, methodological deficits in most of the identified studies became 448 
apparent. Recommendations for future evaluation studies include: (1) clear definition of target user 449 
group by valid, specific impairment-based criteria; (2) adequate selection of subjects with predefined 450 
inclusion criteria representative for potential users; (3) inclusion of other assistive mobility devices for 451 
comparison; (4) inclusion of the habitual use of advanced prototypes in evaluation rather than mere 452 
short-term, restricted, experimental test scenarios for single functionalities of prototypes not finalized 453 
for use in the target user group; (5) selection of established, standardized, and validated assessment 454 
methods; (6) implementation of a specifically tailored assessment strategy, focusing on specific 455 
functionalities of the RR, and (7) statistical analysis of study results. These recommendations, given 456 
for RRs, may also apply in general for the development and evaluation of AAL systems with focus on 457 
the user perspective. 458 
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Table 1. Overview of the search term used in PubMed 
Assistive mobility device Robotic functionality Gait/mobility support Evaluation measure 
#1 ‘robotics’[Mesh] 
#2 ‘walkers’[Mesh] 
#3 ‘self-help devices’[Mesh] 
#4 ‘biomedical technology’[Mesh] 
#5 robot*[tiab] 
#6 rollator*[tiab] 
#7 mobile platform*[tiab] 
#8 mobility aid*[tiab] 
#9 mobility device*[tiab] 
#10 assistive device*[tiab] 
#11 assistive system*[tiab] 
#12 walking aid*[tiab] 
#13 OR (#1-#12) 
#14 ‘electric power supplies’[Mesh]  
#15 robot*[tiab]  
#16 smart[tiab]  
#17 intelligent[tiab]  
#18 power*[tiab]  
#19 electric[tiab]  
#20 motorized[tiab]  
#21 motorised[tiab]  
#22 OR (#14-#22) 
#23 (#13 AND #22) 
#23 ‘gait’[Mesh]  
#24 ‘Walking’[Mesh]  
#25 ‘Dependent Ambulation’[Mesh]  
#26 gait[tiab]  
#27 walk*[tiab]  
#28 ambulant*[tiab]  
#29 mobility[tiab]  
#30 OR (#23-#29) 
#31 (#13 AND #22 AND #30) 
#32 ‘evaluation studies as topic’[Mesh]  
#33 ‘Technology Assessment, Biomedical’[Mesh]  
#34 evaluat*[tiab]  
#35 assess*[tiab]  
#36 measur*[tiab]  
#37 trial*[tiab]  
#38 experiment*[tiab]  
#39 test*[tiab] 
#40 clinical[tiab] 
#41 OR (#32-#40) 
#42 (#13 AND #22 AND #30 AND 41) 
 
Table 2. Study characteristics and assessment methods of the 28 studies included in this systematic review 
Name of device 
Authors [Ref. No.] 
User group 
definition 
Study sample Study object Study design Assessment methods 





Mou et al. 2012 [161,2] 
PD patients  Study 1 
n = 6 (F = n/a) 
Age: n/a 
PD patients of senior care unit; 
mHY, stage range 1.5-3 
UP  IV: repeated assessment on 
six consecutive days 
TAM: gait analysis on straight walking pathb; CAIROW gait analysis system (based 
on LRF)b: SD of gait speed/step length; expert rating of gaitd: number of abnormal 
gait patterns (festinating gait, freezing of gait) 
UE OB SEM: user commentsc after gait analysis  
Study 2 
n = 7 (F = n/a) 
Mean age: 86 yrs 
PD patients of senior care unit; 
mHY, stage range 1-3 
UP  Inter-DC: walking with 
CAIROW vs. normal 
walking (with own/ with-
out assistive device) 
TAM: gait analysis on walking path with obstacles, people randomly passing by, up- 
and down-going slopes, short section for backward walkingd; CAIROW gait analysis 
systemb or LRFc placed in test environment when normal walking: SD of gait 
speed/step length; expert rating of gaitd: number of abnormal gait patterns 
TC (gait analysis 
system) 
EC: gait analysis system 
vs. expert rating 
TEM (see original article for details) 
Care-O-bot II 
Graf 2009 [26] 
Elderly people in 
home environment 
n = 6 (F = 5) 
Age range: 86-92 yrs 
Inhabitants of an old people’s 






motion control) vs. direct 
control mode (user-deter-
mined motion control) vs. 
conventional walker 
TAM: navigation trail in old people’s residence with a ramp, tables, and people 
randomly passing byd; robot’s guidance systemc, bicycle speedometerc mounted on 
conventional walker: walking time, number of collisions, maximum speed, walking 
distance, distance to obstacle 
PHY: force/torque sensorsc in robot’s handles, force measurement when using 
conventional walker not reportedd: pushing force  
UP OB TAM: navigation trail in old people’s residence with transition between ground floor 
and 1st floor, a ramp, tables, people randomly passing byd: achievement of target  
UE OB SEM: questionnaireb after navigation trail: n/a 
Chugo group walker 
Chugo et al. 2009 [30] 
Elderly people in 
need for nursing in 
daily routine 
n = 7 (F = n/a) 
Age: ≥ 67 yrs 
People in need of long-term care at 
level I or II in Japanese Long-term 
Insurance System 
UE Inter-/intra-DC: STS 
transfer without assistance 
vs. with previous/novel 
STS assistance system  
SEM: questionnaireb after STS transfer : ease of standing up, fear of falling (1= 




Wasson et al. 2008 
[22] 
Elderly people n = 12 (F = 2) 
Mean age (SD): 36.8 (18.1) yrs 
Healthy subjects (n = 8), subjects 
with disorders affecting mobility 
(cerebral palsy, familial torsion 
dystonia) (n = 8) 
note: (1) total sample, (2) - (5) 
subsample: only healthy subjects  
TC (guidance, user 
intent detection and 
obstacle avoidance 
system)  
OB TEM (see original article for details) 
TC (obstacle 
avoidance system with 
vs. without stability 
preservation) 
Intra-DC: standard vs. 
stability-preserved obstacle 
avoidance 
TEM (see original article for details) 




Jang et al. 2008 [33] 




up to 75 kg 
n = 2 (F = 0) 
Mean age (SD): 28.5 (2.1) yrs 
Ordinary adult males  
TC (guidance system) OB TEM (see original article for details) 
PD Intra-DC: 40/20 % body 
weight support vs. full 
body weight 
PHY: EMGa during straight walking with standardized gait speed of 0.2 m/s: muscle 
activity of lower extremities (EMG signal) (quadriceps, hamstrings, gastrocnemius, 
tibialis anterior) 
Table 2. (continued) 
Name of device 
Authors [Ref. No.] 
User group 
definition 
Study sample Study object Study design Assessment methods 
Type: outcome measurement: outcome variable 
Guido 
Rentschler et al. 2008 
[34] 
Frail elderly people 
with visual 
impairment  
n = 17 (F = n/a) 
Mean age (SD): 85.3 (7.0) yrs 
Residents of a supportive living 
facility/nursing home with visual 
impairment due to macular 
degeneration, cataract, glaucoma 
or other reasons; mean time (SD) 
since onset of visual impairment: 
20.4 (13.0) yrs; ambulatory ( 20 
min within 90 min period) with 
limited assistance 
UP Inter-/intra-DC: Guido vs. 
conventional assistive 
mobility device or normal 




control) vs. manual mode 
(shared user-robot motion 
control) 
TAM: obstacle course with randomly placed obstacles before each triald: walking time, 
number of obstacle/wall collisions, number of reorientations 
UE PPC: before and after 3 
trials  
SEM: Subjective Mobility Questionnaireb after obstacle course: appearance, ease of 
use, usefulness in living enviroment, embarrassment (1 = best score; 5 = worst score) 
Hitachi walker 
Tamura et al. 2001 
[32] 
Elderly people who 
have difficulty 
walking  
n = 6 (F = n/a) 
Mean age (SD): 82 (7.9) yrs 
Subjects ambulatory with 
supervision (n = 4), subjects in 
need for walking assistance (n = 2) 
UP 
PD 
Inter-DC: Hitachi vs. 
caster vs. conventional 
walker; robot vs. parallel 
bars  
 
CPM:10MWTa: gait speed 
PHY: EMGc, tri-axial accelerometerc during non-standardized gait speed (10MWT): 
muscle activity (EMG signal), trunk acceleration 
HUST walking-aid 
robot 
Xu et al. 2013 [23] 
Elderly or disabled 
people 
n = 3 (F = n/a) 
Age: n/a 
Volunteering subjects with/ 
without experience using robot; 
one subject with restricted knee 
joint to imitate lower limb 
disorders 
TC (motion control 
system)  
PPC: autonomous learning 
process of HUST in 
motion behavior over a 
series of trials  
TEM (see original article for details) 
 
UE OB SEM: subjective evaluation after completing a series of obstacle courses, assessment 
measure not reportedd: flexibility, comfort, maneuverability, obstacle avoidance 
i-Go  
Ko et al. 2014 [24] 
Elderly people n = 3 (F = n/a) 
Age: “in their twenties” 
TC (guidance system) 
UE 
OB TEM (see original article for details) 
SEM: user commentsd after completing an S-shaped walking path 
Intelligent Mobility 
Platform (IMP) 
Glover 2003 [29] 
Older adults 
(primarily without 
major visual or 
cognitive 
impairment) 
n = 6 (F = n/a) 
Age: n/a 
Residents of a care facility with/ 
without need for walker 
UE  OB SEM: user commentsd after presentation and informal testing of the robot  
iWalker 
Kulyukin et al. 2008 
[27] 
Persons with stroke, 
early- to mid-stage 





primarily in nursing 
and assisted living 
homes 
n = 4 (F = n/a) 
age: n/a 
Clients of in-home supportive 
service currently using cane, 
walker or bot, with history of way 
finding problems; MMSE, mean 
score (SD): 26 (3.6) 
UP Inter-DC: iWalker vs. 
conventional device 
(cane/walker) 
accompanied by researcher 
TAM: several navigation trailsb : walking time, number of navigational mistakes 
UE  Intra-DC: map-based (+ 
auditory cues) vs. text-and-
arrow-based (+ auditory 
cues) user interface design 
SEM: dichotomous questionb: choice of user interface; user commentsd 
Table 2. (continued) 
Name of device 
Authors [Ref. No.] 
User group 
definition 
Study sample Study object Study design Assessment methods 






n = 20 (F = 11) 
Mean age: 59.9 yrs 
Acute hemiparetic stroke patients 
(event < 1 yrs) receiving 
rehabilitation treatment; MMSE 
score ≥ 20; CNS upper & lower 
limb > 0 
UP IV (RCT): robot-assisted 
ambulatory training (EG) 
vs. in parallel bars (CG) (4 
weeks, 5x a week) 
CPM: POMAa: total score; 6mWTa: walking distance; 10MWTa: gait speed 
ADL screening: Barthel ADL Indexa: score 
i-Walker (Japan) 









n = 6 (F = 2) 
Mean age (SD): 88.7 (6.1) yrs 
Residents of elder care facility 
with wheelchair due to loss of 
vision/muscle strength which 
occasionally train walking with 
forearm caster walker; chronic 
disease: stroke, dementia, muscle 
atrophy, high blood pressure, heart 
failure, AD, cataract, PD 
UP  Intra-DC: passive vs. 
active robot motion control 
system 
TAM: walking path with obstaclesb, robot-integrated web camerac: deviations from a 




Lee et al. 2014 [38] 
Elderly people with 




n = 5 (F = 4) 
Age range: 75-84 yrs 
Subjects using traditional walkers 
in daily routine  
UE  Inter-DC: JARoW vs. 
conventional walker 
SEM: questionnaireb after walking around for 10 min: ease of walking, safety, 
maneuverability, suggestions for improvements 
MOBIL walking & 
lifting aid 
Bühler et al. 2001 
[181] 




n  2 (F = n/a) 
Age: n/a 
Selected users, technical and 
rehabilitation experts 
TC (overall system 
functionality) 
UE 
OB TEM (see original article for details) 
SEM: user/expert ratings, comments and interviewsd 
MOBIL test bed 
[182] 




n  2 (F = n/a) 
Age: n/a 
Rehabilitation engineers, walking 
impaired persons 
TC (overall system 
functionality) 
OB TEM (see original article for details) 
MOBIL walking & 
lifting aid, MOBIL 
test bed  
[183] 




n  2 (F = n/a) 
Age: n/a 
Community-dwelling people, 
institutionalized elderly disabled 
people, care staff 
UE OB SEM: questionnaireb after demonstration, video presentations, practical trials: n/a  
 
Table 2. (continued) 
Name of device 
Authors [Ref. No.] 
User group 
definition 
Study sample Study object Study design Assessment methods 
Type: outcome measurement: outcome variable 
Nomad XR 4000 
Morris et al. 2003 [28] 
Frail older people 
with cognitive 
impairment 
n = 4 (F = n/a) 
Age: n/a  
Residents of a retirement facility 
UP Intra-DC: passive (no 
navigational assistance) vs. 
active (with navigational 
assistance) vs. forced 
mode (full robot motion 
control)  
TAM: navigational traild; robot’s navigation system (based on LRF, ‘Monte Carlo 
localization’)a: deviation from optimal path  
 
UE OB SEM: user comments after navigational trailsd 




Yu et al. 2003 [171,2] 
Independently living 
or institutionalized 
elderly people with 
mobility difficulties 
due to physical 
frailty and/or 
disorientation due to 
age and sickness 
Study 1 
n = 8 (F = n/a) 
Age: n/a 
Elderly residents of assisted living 
facility with mobility aid 
UE OB SEM: questionnaireb after free driving at facility: ease of control, going straight, 
turning, heaviness, support, satisfaction (1 = worst score, 5 = best score) 
Study 2 
n = 8 (F = 5) 
Age range: 84-95 yrs 
Elderly residents of assisted living 
facility with need for walkers 
UP Intra-DC: full robot motion 
control vs. adaptive shared 
user-robot motion control 
vs. without any motion 
control 
TAM: wall-limited walking path through assisted living facilityd; robot’s vision-based 
localization system (based on charged-coupled device camera)b: deviations from 
robot-generated, pre-planned path, distance to wall 
UE OB SEM: user commentsd 
Robotic Mobility 
Platform (RMP) 
Grondin & Qinggou 
2013 [19] 
n/a n = 10 (F = 5) 
Mean age (SD): 24.6 (3.0) 
Subjects without previous/current 
gait-related injuries and without 
experience in using rollators or 
robotic walkers 
UP, PD Intra-DC: novel vs. 
previous motion control 
system 
TAM: walking with targeted velocity of 1 m/s through a circular path in low-traffic 
hallwaysb; technical outcome measurement not reportedd: mean and SD of robot 
velocity; PHY: force/torque sensora under robot’s left handle: pushing force 
PD Inter-/intra-DC: novel vs. 
previous motion control 
system vs. conventional 
rollator vs. no assistive 
device 
PHY: walking with targeted velocity of 1 m/s through the circular pathc (use of a Hall 
effect sensor mounted on the conventional rollator to display target velocity); 
respirometrya: metabolic cost of transport, oxygen consumption 
UE Intra-DC: novel vs. previous 
motion control system 
SEM: questionnaireb: comfort, intuition, speed control, exertion, overall experience (0 
= worst score, 5 = best score) 
robuWALKER 
Rumeau et al. 2012 
[21] 
elderly people n = 8 (F = 5) 
Mean age (SD): 82.6 (8.7) yrs 
Healthy elderly (n = 4): 4MWT < 
4s, TUG < 13s, MMSE score ≥ 26; 
elderly patients with motor & 
cognitive impairment (n = 4): 
4MWT > 4s, TUG > 13s, MMSE 
mean score (SD): 20 (3.5); all 
subjects without experience in 
using walking frames 
UP Inter-DC: robuWalker vs. 
conventional walker 
CPM: 4MWTa: gait speed, modified TUGa: completion time; gait analysis by video 
recordingsc during 4MWT and TUG: step time, double support time 
Table 2. (continued) 
Name of device 
Authors [Ref. No.] 
User group 
definition 
Study sample Study object Study design Assessment methods 
Type: outcome measurement: outcome variable 
Robotic Travel Aid 
(RoTA) 




patients, or residents 
of senior homes 
loss of ability to 
walk with mobility 
aids for the blinds 
n > 60 (F = n/a) 
Age: n/a 
Blind and weak-sighted elderly 
people 
UE OB SEM: user commentsd after walking course 
RT Walker 
Taghvaei et al. 2010 
[20] 
n/a n = 2 (F = n/a) 
Age: n/a 
 
TC ( motion control 
system) 
OB TEM (see original article for details) 
 
SIMBIOSIS Walker 
Frizera-Neto et al. 
2011 [12] 
SCI patients mainly 
using wheelchair, 
but usually able to 
walk for short 
periods of time with 
assistance of device, 
WISCI II = 16 
 
n = 8 (F = n/a) 
Age: n/a 
Subjects with preserved cognitive 
functions; ability to (1) maintain 
standing position, (2) walk 10 m 
without assistance of another 
person and with or without support 
of a mobility aid, and (3) to grasp; 
WISCI II, mean score (SD): 15.9 
(2.9) 
TC (user intent 
detection system) 
OB TEM (see original article for details) 
UE OB SEM: questionnaireb after completing U-shaped walking path: maneuverability, safety, 
posture & comfort (0 = worst score, 100 = best score) 
Smart Mobile 
Walker (SMW) 




with incomplete SCI 
 
n  2 (F = n/a) 
Age: n/a 
Stroke patients, SCI patients, 
clinical experts 
UE OB SEM: user comments/interviewsd after demonstrations 
Walking Helper 
Hirata et al. 2005 [25] 
elderly people, 
disabled people 
n = 8 (F = n/a) 
Age: n/a 
UP Intra-DC: novel vs. 
traditional motion control 
system 
TAM: following S-shaped walking pathb (marked on the floor); technical outcome 
measurement not reportedd: deviation from path marked on the floor 
Abbreviations: PD = Parkinson’s disease; F = females; n/a = not available; mHY = modified Hoehn and Yahr Scale; UP = User performance; UE = User experience; IV = interventional; OB = observational; TAM = tailored 
assessment measure; LRF = laser rangefinder; SD = standard deviation; SEM = subjective evaluation measure; TC = technical capability; inter-DC = inter-device comparative; EC = comparison with external criterion measure; 
TEM = technical evaluation measure; PD = physical/physiological demands; intra-DC = intra-device comparative; PHY = evaluation of physical or physiological demands; STS = sit-to-stand; EMG = electromyography; PPC = 
pretest-posttest comparative; CPM = clinical performance-based measure; 10MWT = 10-meter walk test; MMSE = Mini-Mental State Examination; CNS = Canadian Neurological Scale; RCT = randomized controlled 
intervention trial; EG = experimental group; CG = control group; POMA = Performance Oriented Mobility Assessment; 6mWT = 6-minute walk test; ADL = activities of daily living; AD = Alzheimer’s disease; FAC = 
Functional Ambulation Classification; TUG = Timed Up and Go; 4MWT = 4-meter walk test; WISCI = Walking Index for Spinal Cord Injury; SCI = Spinal Cord Injury. 
a established, standardized and validated assessment test or outcome measurement. 
b standardized, but not validated test procedure or outcome measurement. 
c potentially an established outcome measurement, but no reference given.  
d non-standardized or unclear test procedure or outcome measurement. 
 
